Exagen (XGN) Total Non-Current Liabilities (2018 - 2026)
Exagen's (XGN) quarterly Total Non-Current Liabilities came in at $36.8 million in Q1 2026, up 8.85% YoY from $33.8 million in Q1 2025, and down 5.31% on a QoQ basis from $38.8 million in Q4 2025.
Exagen (XGN) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends
Exagen (XGN) has 9 years of Total Non-Current Liabilities data on file, last reported at $36.8 million in Q1 2026.
- Quarterly Total Non-Current Liabilities rose 8.85% year-over-year to $36.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $36.8 million (up 8.85% YoY) and the FY2025 annual result came in at $38.8 million, up 10.45% from the prior year.
- Total Non-Current Liabilities fell to $36.8 million in Q1 2026, from $38.8 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $45.1 million in Q1 2022 to a low of $30.5 million in Q1 2024.
- A 5-year average of $37.0 million and a median of $36.8 million in 2026 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Non-Current Liabilities climbed 29.28% — and 2024, when it retreated 28.24%.
- Tracing XGN's Total Non-Current Liabilities over 5 years: stood at $42.9 million in 2022, then slipped by 20.98% to $33.9 million in 2023, then gained by 3.71% to $35.1 million in 2024, then climbed by 10.45% to $38.8 million in 2025, then slipped by 5.31% to $36.8 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $36.8 million (Q1 2026), $38.8 million (Q4 2025), and $38.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 108.64 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 85.84 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 542.10 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 5.45 Bn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 22.94 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 737.18 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 6.36 Bn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 3.39 Bn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 15.88 Bn |
| 10 | Exagen | 158.28 Mn | 133.68 Mn | 12.22 Mn | 38.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 38.53 Mn |
| Mar 31, 2026 | 36.76 Mn |
| Dec 31, 2025 | 38.82 Mn |
| Sep 30, 2025 | 38.05 Mn |
| Jun 30, 2025 | 37.64 Mn |
| Mar 31, 2025 | 33.77 Mn |
| Dec 31, 2024 | 35.15 Mn |
| Sep 30, 2024 | 30.55 Mn |
| Jun 30, 2024 | 31.50 Mn |
| Mar 31, 2024 | 30.55 Mn |
| Dec 31, 2023 | 33.89 Mn |
| Sep 30, 2023 | 32.94 Mn |
| Jun 30, 2023 | 31.68 Mn |
| Mar 31, 2023 | 42.57 Mn |
| Dec 31, 2022 | 42.89 Mn |
| Sep 30, 2022 | 44.41 Mn |
| Jun 30, 2022 | 43.22 Mn |
| Mar 31, 2022 | 45.13 Mn |
| Dec 31, 2021 | 37.10 Mn |
| Sep 30, 2021 | 35.54 Mn |